Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Completed · Phase 2 · Has a placebo group

Conditions studied: Fibromyalgia, Sleep, Chronic Pain

In brief

Fibromyalgics frequently report sleep disturbances, in particular poor and unrefreshing sleep. Additionally, studies have reported that sleep problems, pain and mood disturbances are associated in patients with fibromyalgia. By improving the quality of sleep, complaints of poor and unrefreshing sleep, fatigue, pain, which are among the main components of this chronic pain disorder may be improved.

Key facts

Study ID
NCT00313885
Run by
Sanofi
People needed
205
Starts
2004-04-01
Expected to finish
2005-06-01
Last updated by the study team
2010-11-30

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.